Mean weight loss with semaglutide 2.4 mg
Over 68 weeks in the STEP-1 trial of 1,961 adults with overweight or obesity — vs. 2.4% with placebo.
STEP-1 · Wilding et al., NEJM 2021 ↗Spring Special — $179 first month + Free 1-2 Day Shipping · Cancel Anytime




Clinically-Studied GLP-1 Weight Loss*
Not another 30-day fix. A medically-guided weight management program — GLP-1 treatment designed around your body, your goals, and your life — starting at $179 your first month. No hidden fees.
Available in most U.S. states · Licensed providers in your state
*Up to 20.9% average body weight loss over 72 weeks with tirzepatide 15mg in the SURMOUNT-1 trial (Jastreboff et al., N Engl J Med 2022); up to 14.9% over 68 weeks with semaglutide 2.4mg in the STEP-1 trial (Wilding et al., N Engl J Med 2021). Results are from studies of FDA-approved branded medications and may not reflect outcomes with compounded formulations. Individual results vary; weight loss is not guaranteed.
Research Published In
AvataCore treatment protocols are informed by clinical data from peer-reviewed research.
Avg. body weight reduction with semaglutide 2.4mg at 68 weeks1
Avg. body weight reduction with tirzepatide 15mg at 72 weeks2
Of STEP 1 participants lost ≥5% of body weight1
Licensed provider support via our clinical partner
1 Wilding et al., N Engl J Med 2021 (STEP 1) · 2 Jastreboff et al., N Engl J Med 2022 (SURMOUNT-1)
Individual results vary. Trial data does not guarantee outcomes.
Built for Clinical Trust
US-Licensed Providers
Board-certified MDs & NPs
HIPAA Compliant
End-to-end encryption
US-Based Pharmacy
State-licensed
HSA/FSA May Apply*
Use pre-tax dollars
30-Day Guarantee
Consultation refund if not prescribed
Find the right GLP-1 medication with the confidence that comes from knowing it is doctor-approved and budget-friendly.

Starting at $179
One simple injection per week.
30-day money-back guaranteeTake the Quiz
$249 first mo†
One dissolvable tablet per day.
30-day money-back guaranteeTake the Quiz
$279 first mo†
Dual-agonist GLP-1 + GIP, weekly injection.
30-day money-back guaranteeTake the QuizAverage body weight reduction reported in peer-reviewed GLP-1 trials
Trial data reflects FDA-approved formulations of semaglutide and tirzepatide. Compounded formulations contain the same active ingredients; outcomes with compounded preparations may differ. Individual results vary based on dose, adherence, diet, and other factors. Weight loss is not guaranteed. References: Wilding JPH et al., NEJM 384:989-1002 (2021); Jastreboff AM et al., NEJM 387:205-216 (2022).
Start your weight management journey today with AvataCore's easy, personalized process for accessing GLP-1 medications. Designed with your convenience in mind, our streamlined approach ensures you're supported every step of the way, from approval to receiving your prescription.

Complete a quick online evaluation to determine if GLP-1 medication is right for you. Our team of licensed professionals will review your information and provide approval in no time.

Once approved, you'll receive personalized care and a prescription to support your weight loss and health goals. Your care plan is designed to help you achieve lasting results safely and effectively.

Your medication will be shipped directly to your door for maximum convenience. With AvataCore, starting your treatment is as simple as opening your package and following our easy-to-use instructions.
Free to start · No credit card required


AvataCore provides 24/7 access to a dedicated team of specialists, ensuring you have the support you need around the clock. With unlimited appointments, messaging and support, you can confidently reach out for guidance, ask questions, or address concerns at any time.
Unlimited Messaging
Chat with your care team anytime
24/7 Availability
Support when you need it most
Dedicated Specialists
A team that knows your journey
No Extra Cost
All included in your plan
From Peer-Reviewed Research
Six findings from the pivotal GLP-1 trials that define how we build our care plans. No cherry-picked quotes — just the numbers from the peer-reviewed record.
Over 68 weeks in the STEP-1 trial of 1,961 adults with overweight or obesity — vs. 2.4% with placebo.
STEP-1 · Wilding et al., NEJM 2021 ↗Over 72 weeks in the SURMOUNT-1 trial of 2,539 adults — the highest reduction in any published GLP-1 study to date.
SURMOUNT-1 · Jastreboff et al., NEJM 2022 ↗Clinically meaningful weight reduction threshold reached by the vast majority of STEP-1 participants — the benchmark providers care about.
STEP-1 · Wilding et al., NEJM 2021 ↗Pooled GLP-1 trial arms showed 6× the weight reduction of placebo + lifestyle modification groups over the same duration.
STEP / SURMOUNT pooled control arms ↗Appetite, satiety, and metabolic set point are largely governed by hormones — not willpower. GLP-1 works with your biology, not against it.
Obesity is a chronic disease · AMA 2013 ↗Pivotal trials run 68–72 weeks. Weight loss continues throughout — which is why our care plans are built for the long arc, not 30 days.
STEP-1 · SURMOUNT-1 ↗Trial data reflects FDA-approved formulations. Compounded preparations contain the same active ingredients; outcomes may differ. Individual results vary. Weight loss is not guaranteed.
We only charge for care you can actually receive. Your trust is our top priority — from consultation to your door.

If you are not a candidate for GLP-1 therapy after your provider consultation, you receive a full refund of your first payment — no questions asked.
If your medication is lost or damaged in transit, we will resend at no additional charge. We stand behind every shipment.
Your health information is protected under HIPAA and will never be sold. Plain, discreet packaging on every delivery.
Start your weight management journey today. Our process is fast, simple, and backed by licensed providers.
Take the Quiz → It's FreeNo credit card required · Free shipping · Cancel anytime